Fulminant myocarditis in a patient with coronavirus disease 2019 and rapid myocardial recovery following treatment

Hawkins C. Gay*, Arjun Sinha, Eriberto Michel, Anthony B. Mozer, Ashley Budd, Matthew J. Feinstein, Keith H. Benzuly, Abbas Al-Qamari, Amit A. Pawale, Esther E. Vorovich

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

1 Scopus citations

Abstract

Coronavirus disease 2019 (COVID-19) is a global pandemic increasingly encountered in the clinical setting. It typically manifests as a respiratory illness, although cardiac involvement is common and portends a worse prognosis. We present the case of a 56-year-old male admitted with COVID-19 fulminant myocarditis and cardiogenic shock. We discuss important aspects of the multidisciplinary and interventional care involved in treating cardiogenic shock as well as the likely mechanisms of, and potential treatment for, COVID-19 myocarditis. The various pathways of myocardial injury, including direct viral damage, macrophage activation, and lymphocytic infiltration, are outlined in detail in addition to associated pathology such as cytokine release syndrome. COVID-19 is a complex and multisystem disease process; in addition to supportive care, specific consideration should be given to the underlying mechanism of injury for each patient.

Original languageEnglish (US)
Pages (from-to)4367-4370
Number of pages4
JournalESC Heart Failure
Volume7
Issue number6
DOIs
StatePublished - Dec 2020

Keywords

  • COVID-19
  • Cardiogenic shock
  • Echocardiography
  • Mechanical support
  • Myocarditis

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Fingerprint

Dive into the research topics of 'Fulminant myocarditis in a patient with coronavirus disease 2019 and rapid myocardial recovery following treatment'. Together they form a unique fingerprint.

Cite this